Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G10 | O15496 | 3/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | CTSC | P53634 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.35 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 2/20 | 0.35 |
| ▸ | NMT2 | O60551 | 1/20 | 0.35 |
| ▸ | NMT1 | P30419 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20438368 | 0.80 | PLA2G10 (0.44) | PLA2G10ALDH1A1LMNASLC7A5 | |
| SCHEMBL6447013 | 0.79 | ALDH1A1 (0.58) | ALDH1A1LMNA | |
| SCHEMBL6447009 | 0.79 | ALDH1A1 (0.58) | ALDH1A1LMNA | |
| SCHEMBL16351240 | 0.79 | DNM1 (0.54) | PLA2G10DNM1CTSCCACNA2D1CACNB3 | |
| SCHEMBL8367141 | 0.78 | DNM1 (0.48) | DNM1LMNA | |
| SCHEMBL3205737 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL15987810 | 0.76 | MEN1 (0.52) | DNM1ALDH1A1 | |
| SCHEMBL22604163 | 0.74 | SMN1; SMN2 (0.40) | DNM1ALDH1A1 | |
| SCHEMBL29239631 | 0.74 | — | — | |
| SCHEMBL434917 | 0.72 | ALDH1A1 (0.50) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11572558-B2 | Single-stranded oligonucleotide | NISSAN CHEMICAL CORPORATION (JP) | 2023-02-07 | — | — | US | disclosed |
| US-20210254055-A1 | SINGLE-STRANDED OLIGONUCLEOTIDE | NISSAN CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11572558-B2 | Single-stranded oligonucleotide | MLX, ZFX, UPF1 | PLA2G10 2410/4885DNM1 974/4885CTSC 4270/4885 |
| US-20210254055-A1 | SINGLE-STRANDED OLIGONUCLEOTIDE | MLX, ZFX, UPF1 | PLA2G10 2410/4885DNM1 974/4885CTSC 4270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.